Cells expressing HCCR-1 are tumourigenic in nude mice [1] . The functional role of HCCR-1 oncogene in tumourigenesis is manifested as a negative regulator of the p53 tumour suppressor [1] . Previous study showed that the HCCR-1 is overexpressed in breast cancer cell lines compared to the normal cells [2] . Serological studies revealed 86.8% sensitivity for HCCR-1 in breast cancer, which was higher than 21.0% for 3] 
Introduction
Cells expressing HCCR-1 are tumourigenic in nude mice [1] . The functional role of HCCR-1 oncogene in tumourigenesis is manifested as a negative regulator of the p53 tumour suppressor [1] . Previous study showed that the HCCR-1 is overexpressed in breast cancer cell lines compared to the normal cells [2] . Serological studies revealed 86.8% sensitivity for HCCR-1 in breast cancer, which was higher than 21 .0% for CA15-3 [2, 3] . The HCCR-1 assay has an advantage over CA15-3 in diagnosing breast cancer. These results indicate that HCCR-1 is an oncoprotein that is related to breast cancer development [1, 2] . The HCCR-1 signalling is known to be regulated by the phosphatidylinositol 3'-kinase-AKT pathway [4] .
Apolipoprotein E (ApoE) is a key regulatory protein in lipoprotein metabolism [5] and it is also a potent inhibitor of cell proliferation [6, 7] . Apo E is capable of inhibiting the growth of several tumour cell lines including breast carcinoma cells [7] , melanoma cells [7] and Kaposi's sarcoma cells [6] . Recombinant human ApoE-3 inhibited human breast cancer and melanoma cell proliferation by competition for growth factor binding to proteoglycans and by an anti-adhesive activity of ApoE [7] . Despite intensive research, the anti-proliferative mechanism of ApoE is still largely unknown. In part, this is due to the emerging multiplicity of interactions of ApoE with other molecules, and by an increasingly complex cascade of ApoE-dependent signalling and metabolic pathways.
It is generally accepted that obese women have an increased risk for post-menopausal breast cancer [8] [9] [10] . Several hypotheses have been proposed to explain the association of obesity with [11] . One hypothesis is that the biological cause of the association between obesity and breast cancer is the elevated circulating oestrogens in obese post-menopausal women [12] . A second hypothesis is that obesity results in an increase in circulating insulin and insulin-like growth factor [13] . 
Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity

Materials and methods
Tissues and cell lines
Subcellular fractionation
Haematoxylin-eosin staining
All paraffin blocks were processed and cut into 4-m-thick sections. The sections were stained with routine haematoxylin and eosin and were studied to ascertain the morphology of the lesion. 
Co-transfection and immunoprecipitation
Cells were transfected with pcDNA3.1 (Invitrogen) encoding HCCR-1-V5-His (Invitrogen) fusion protein and ApoE-Myc-His (Invitrogen
Production of transgenic mice
Transgenic mice were generated using standard pronuclear microinjection as previously described [15] . (Fig. 1D) . [5] and it is also a potent inhibitor of cell proliferation [6, 7] . Fig. 2C; left-hand panel) and ApoE, in the mitochondria and the cytosol, respectively ( Fig. 2C; right-hand panel) . (Fig. 3A) . On the contrary, the growth rate of HCCR-1-transfected MCF-7 cells was increased by about 45% at day 7 post-transfection compared to controls (Fig. 3A) (Fig. 3B) (Fig. 3D) 
Interaction of HCCR-1 with ApoE and co-localization of HCCR-1 and ApoE in the mitochondria
We next performed subcellular fractionation experiments to investigate the localization of HCCR-1 and ApoE in MCF-7 cells (Fig. 2B). The stably expressed HCCR-1 protein in the MCF-7 cells was detected only in the mitochondria fraction (Fig. 2B; top panel), whereas ApoE was found only in the cytosol fraction in MCF-7 cells stably expressing ApoE (Fig. 2B; bottom panel). Intriguingly, however, subcellular fractionation assay with MCF-7 cells coexpressing HCCR-1 and ApoE revealed the co-localization of these two proteins in the mitochondria fraction, while trace amount of ApoE still remained in cytosol (Fig. 2B; bottom panel). These results indicate that when ApoE is co-expressed with HCCR-1 in MCF-7 cells, ApoE protein might be reshuffled to the mitochondria from the cytoplasm. Fluorescence images also revealed HCCR-1 (
ApoE plays a tumour suppressor role in breast cancer and HCCR-1 negatively regulates ApoE function in breast cancer
To verify the growth inhibitory role of ApoE, ApoE was transfected into breast cancer cells. The ApoE transfection induced about 87% growth inhibition in MCF-7 cells compared with those transfected with vector alone at day 7 post-transfection
HCCR-1 interacting with ApoE induced the severe obesity in transgenic mice
To investigate whether overexpression of HCCR-1 exerts any role related to ApoE function, we generated transgenic mice (T/G) for HCCR-1. The overexpression of HCCR-1 in T/G induced the severe obesity in T/G. Obese mice were bred for more than five generations
and weighed three times more than normal mice with the same age and gender (Fig. 4A) . Of note, obesity was more severe in male T/G ( Fig. 4A; left-hand panel) than female T/G ( Fig. 4A; right-hand (Fig. 4B) . In the transgenic male, the omentum showed a large volume of fat and hypertrophy of adipocytes ( Fig. 4B; top panel) . The liver showed diffuse microvesicular and macrovesicular fatty change in the hepatocytes ( Fig. 4B; top panel) . The pancreas of transgenic male revealed islet cell hyperplasia of Langerhans islands, which had increased number and size of them ( Fig. 4B; top panel) . The heart valves showed moderate myxoid change and hypertrophy ( Fig. 4B; top panel) . Compared with transgenic male, the transgenic female showed the mildly increased cell size and volume of omentum ( Fig. 4B; second panel) . In addition, the islet cell hyperplasia of pancreas and the myxoid change of heart valve appeared less pronounced ( Fig. 4B; second panel) . These defects were not observed in normal control male mice ( Fig. 4B ; bottom panel).
Fig. 2 Interaction of HCCR-1 with ApoE and their co-localization in the mitochondria. (A) Co-immunoprecipitation experiment of HCCR-1 and ApoE showing the direct interaction between HCCR-1 and ApoE. Cell lysate from MCF-7 cells expressing either HCCR-1-V5 or ApoE-Myc, or both was immunoprecipitated with mAb specific for Myc and HCCR-1 was detected by Western blotting using V5 mAb (left-hand panel). Likewise, ApoE interacting with HCCR-1 was detected by Western blotting using Myc mAb after co-immunoprecipitation with V5 mAb (right-hand panel). (B) Subcellular fractionation of HCCR-1 and ApoE in HEK293 cells. Cytosolic (C), nuclear (N) and mitochondrial (M) fractions were prepared from HEK293 cells transfected with HCCR-1, ApoE or both and analysed by SDS-PAGE and immunoblotting using antibodies, V5 and c-Myc for HCCR1 (top panel) and ApoE (bottom panel), respectively. The Voltage Dependant Anion Channel 1 (VDAC1) was used as a mitochondrial marker. (C) Fluorescence microscopy. Cells were transiently transfected with pEGFP-HCCR-1 (left-hand panel) and pEGFP-ApoE (right-hand panel) using LipofectAMINE 2000 (Invitrogen). Cells were incubated with 25 nM MitoTracker (Molecular Probes). Cells were then mounted using ProLong Gold Antifade Reagents. Fluorescent images were analysed by a Bio-Rad MRC-1024MP laser scanning confocal microscope (Bio-Rad).
The expression profile of HCCR-1 and ApoE was contrasting to one another on the Western blot consisting of several tissues derived from control and T/G (Fig. 4C) (Fig. 4C) . Thus, this mutually exclusive expression pattern of HCCR-1 and ApoE reminiscent of the data shown in Fig. 1A and B might indicate that they are regulated differently but in a coordinated manner by signalling pathways, eventually leading to opposite biological consequences.
There is also accumulating evidence implicating the role for serum lipids in many cancers and other chronic diseases [16] [17] [18] . In general, low serum cholesterol levels and high serum triglycerides have been implicated as possible biological markers for increased susceptibility to cancers of the colon, lung, prostate and breast. High serum triglyceride levels were positively associated with breast cancer risk [16] [17] [18] (Fig. 4D) (Fig. 4D) . But there were no significant differences in ApoE, leptin and insulin secretions between obese mice and normal control mice of same age (Fig. 4D) . The levels of ApoE in obese male and female mice, and control mice were 0.9 Ϯ 0.06 mg/dl, 0.9 Ϯ 0.05 mg/dl and 1.4 Ϯ 0.30 mg/dl, respectively (Fig. 4D) (Fig. 4D) . Serum insulin levels were not different between obese mice and normal control mice (Fig. 4D) . The levels of insulin in obese male and female mice, and control mice were 2.3 Ϯ 0.6 IU/ml, 2.0 Ϯ 0.3 IU/ml and 2.0 Ϯ 0.6 IU/ml, respectively. Therefore, our in vivo data using T/G mice demonstrate that HCCR-1 might be a key regulator of lipid metabolism probably by controlling ApoE function such as cholesterol-lowering effect.
Obesity is associated with higher-grade breast cancers, especially in black women [19] . In addition, obesity affects changes in hormones, which influence breast cancer growth, including oestrogens, androgens, insulin-like growth factors and insulin [20] . Although attention has been reasonably focused on oestrogen as a potential mediator of the obesity influence on breast cancer [21] , emerging evidence suggests that insulin levels also could play a role. Both higher fasting insulin levels and obesity independently predict a significantly increased risk of recurrence and decreased survival in a breast cancer cohort [13] . In Fig. 3 HCCR-1 [22, 23] .
In this study, we found that the molecular mechanism by which HCCR-1 contributes to the breast cancer involves inhibiting the anti-proliferative role of the ApoE probably through the direct association. Our findings that HCCR-1 interacts with ApoE, a key regulator of lipid metabolism and HCCR-1 T/G exhibit the pathological defects related to the obesity provide the molecular evidences for the association of the obesity with a breast cancer.
In 
